Synthetic strategies of nonpeptidic β‐secretase (BACE1) inhibitors
- 1 January 2009
- journal article
- review article
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 46 (1) , 10-17
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Discovery of Isonicotinamide Derived β-Secretase Inhibitors: In Vivo Reduction of β-AmyloidJournal of Medicinal Chemistry, 2007
- Therapies for Alzheimer's diseaseNature Reviews Drug Discovery, 2007
- Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind β-secretase in a N-terminal 10s-loop down conformationBioorganic & Medicinal Chemistry Letters, 2007
- Evaluating scoring functions for docking and designing β-secretase inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Acylguanidines as Small-Molecule β-Secretase InhibitorsJournal of Medicinal Chemistry, 2006
- BACE-1 inhibition by a series of ψ[CH2NH] reduced amide isosteresBioorganic & Medicinal Chemistry Letters, 2006
- Conformationally biased P3 amide replacements of β-secretase inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Design and Synthesis of Hydroxyethylene-Based Peptidomimetic Inhibitors of Human β-SecretaseJournal of Medicinal Chemistry, 2003
- Structure-Based Design: Potent Inhibitors of Human Brain Memapsin 2 (β-Secretase)Journal of Medicinal Chemistry, 2001
- Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 3. Structure−Activity Studies of Ketomethylene-Containing PeptidomimeticsJournal of Medicinal Chemistry, 1999